Understanding Your CLN4 (Kufs Disease) Diagnosis

A diagnosis of CLN4, also known as Kufs disease, often marks the end of a long and difficult search for answers. Because it is extremely rare and shares symptoms with many other neurological conditions, it is common for patients to face a “diagnostic odyssey” lasting years before the correct cause is found ^[1][2].

CLN4 is an adult-onset neuronal ceroid lipofuscinosis (ANCL). This is a group of rare, inherited disorders that cause the buildup of fatty substances called lipofuscin (often called “wear-and-tear pigment”) within the brain’s nerve cells ^[3]. While many other forms of this disease (collectively known as Batten disease) begin in childhood and cause rapid vision loss, CLN4 typically begins in adulthood and, crucially, your vision is generally preserved ^[4][5].

Understanding the Terms

The terminology used for this condition can be confusing. It is helpful to distinguish between the clinical symptoms and the genetic cause:

• Kufs Disease: This is an “umbrella term” for adult-onset forms of the disease based on clinical symptoms ^[6].
• CLN4: This refers specifically to the form of Kufs disease caused by a mutation in the DNAJC5 gene ^[7].
• Inheritance: CLN4 is autosomal dominant, meaning a person only needs to inherit one copy of the mutated gene from one parent to develop the condition ^[8].

Clinical Patterns

Doctors often classify the symptoms into two main patterns, though these categories can sometimes overlap:

• Type A (Progressive Myoclonus Epilepsy): This pattern is characterized primarily by seizures and myoclonus (brief, involuntary muscle jerks or twitches) ^[9][5].
• Type B: This pattern is more likely to involve early cognitive changes or dementia and physical movement issues, such as ataxia (loss of coordination) ^[6][9].

The Diagnostic Journey

Because the symptoms of CLN4—such as seizures, personality changes, or balance problems—can look like many other conditions (such as Huntington’s disease or early-onset Alzheimer’s), doctors may initially suspect more common disorders ^[1][2].

In the past, doctors relied on a skin biopsy to look for storage material under a microscope. However, these biopsies are often unreliable for CLN4 because they can miss the signs or mistake normal age-related pigments for the disease ^[1][6]. Today, genetic testing is the gold standard for diagnosis. It is important that the genetic test used is capable of detecting specific complex mutations like certain insertions or duplications in the DNAJC5 gene, which standard sequencing methods sometimes miss ^[10][11].

Managing the Condition

CLN4 is a progressive condition, meaning symptoms will change and increase over time ^[12]. While there is currently no cure or disease-modifying treatment approved specifically for CLN4, care focuses on managing symptoms and maintaining quality of life ^[13].

Seizure and Movement Safety

Managing seizures and myoclonus is often a priority. This typically involves:

• Working with an epileptologist (a neurologist specializing in epilepsy) to find the right balance of anti-seizure medications ^[9].
• Creating a written seizure action plan that outlines what to do during a seizure and when to use emergency rescue medications.
• Assessing home safety to prevent falls, especially as myoclonus or balance issues progress.

Medication Precautions

Special caution is needed with antipsychotics or other dopamine-blocking drugs. There have been reports of patients with Kufs disease developing neuroleptic malignant syndrome (a life-threatening reaction involving high fever and muscle rigidity) after using these medications ^[14]. This does not mean these medications can never be used, but they should only be used after a careful risk-benefit review by a specialist, starting at the lowest possible dose and monitored closely ^[14].

Building a Support Team

Because CLN4 affects many parts of life, a multidisciplinary care team is essential. This may include:

• Physical and Occupational Therapists to help with mobility and daily tasks ^[15].
• Speech-Language Pathologists to monitor swallowing and communication as the disease progresses ^[16].
• Genetic Counselors to help you and your family understand the risks for other relatives ^[8][6].
• Palliative Care Specialists who focus on relieving symptoms and supporting your emotional and social needs at any stage of the journey ^[15].

Research and the Future

At the time of this publication, check ClinicalTrials.gov as new clinical trials may open. Researchers are actively studying the DNAJC5 gene and testing experimental approaches like iron chelation and lysosomal protection in laboratory models ^[17][12]. Participating in a natural history registry can help researchers better understand how the disease progresses, which is a vital step toward developing future treatments [NCT04613089].